PEMPHIGUS VULGARIS
Clinical trials for PEMPHIGUS VULGARIS explained in plain language.
Never miss a new study
Get alerted when new PEMPHIGUS VULGARIS trials appear
Sign up with your email to follow new studies for PEMPHIGUS VULGARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells target cause of painful blistering disease
Disease control Recruiting nowThis study is testing two new cell therapies for adults with active pemphigus vulgaris, a painful autoimmune disease that causes severe blisters. Researchers are giving patients their own immune cells that have been specially engineered in a lab to target and potentially control …
Matched conditions: PEMPHIGUS VULGARIS
Phase: PHASE1, PHASE2 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Mapping the pain: researchers seek to measure devastating skin blister diseases
Knowledge-focused Recruiting nowThis study aims to better measure the severity and impact of rare autoimmune blistering skin diseases like pemphigus and bullous pemphigoid. Researchers will enroll 150 adults with these conditions to compare different scoring tools and see how disease severity affects quality of…
Matched conditions: PEMPHIGUS VULGARIS
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC